MACQUARIE GROUP LTD - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,610,000
-9.5%
167,2000.0%0.00%0.0%
Q2 2023$1,779,000
+1.1%
167,2000.0%0.00%0.0%
Q1 2023$1,759,000
-15.1%
167,2000.0%0.00%0.0%
Q4 2022$2,072,000
+17.0%
167,200
-2.2%
0.00%0.0%
Q3 2022$1,771,000
-10.2%
170,9900.0%0.00%0.0%
Q2 2022$1,972,000
-8.3%
170,9900.0%0.00%0.0%
Q1 2022$2,151,000
+7.9%
170,9900.0%0.00%0.0%
Q4 2021$1,994,000
-10.7%
170,9900.0%0.00%0.0%
Q3 2021$2,233,000
+4457.1%
170,990
+4411.6%
0.00%
Q2 2021$49,000
+16.7%
3,7900.0%0.00%
Q1 2021$42,000
-97.3%
3,790
-97.2%
0.00%
-100.0%
Q4 2020$1,556,000
+18.0%
136,548
-6.9%
0.00%0.0%
Q3 2020$1,319,000
-15.7%
146,610
-3.4%
0.00%
-33.3%
Q2 2020$1,565,000
+5.7%
151,692
+3.4%
0.00%0.0%
Q1 2020$1,480,000
-19.8%
146,677
+5.9%
0.00%0.0%
Q4 2019$1,845,000
+71.2%
138,569
+10.3%
0.00%
+50.0%
Q3 2019$1,078,000
-72.3%
125,604
-64.6%
0.00%0.0%
Q2 2019$3,885,000
+338.5%
355,026
+500.4%
0.00%0.0%
Q4 2017$886,000
-49.4%
59,128
-46.7%
0.00%
-33.3%
Q3 2017$1,751,000
-62.5%
111,003
-55.1%
0.00%
-66.7%
Q2 2017$4,673,000
+9.6%
247,485
-1.0%
0.01%
+12.5%
Q1 2017$4,265,000
-10.7%
249,986
-20.0%
0.01%
-11.1%
Q4 2016$4,777,000
-6.0%
312,459
-2.4%
0.01%
-10.0%
Q3 2016$5,082,000
+667.7%
320,000
+428.9%
0.01%
+900.0%
Q1 2016$662,000
-5.6%
60,4990.0%0.00%0.0%
Q4 2015$701,000
+11.3%
60,4990.0%0.00%0.0%
Q3 2015$630,000
-13.7%
60,4990.0%0.00%0.0%
Q2 2015$730,000
-24.6%
60,4990.0%0.00%
-50.0%
Q1 2015$968,000
+4.4%
60,4990.0%0.00%0.0%
Q4 2014$927,000
+15.3%
60,499
-2.5%
0.00%0.0%
Q3 2014$804,000
-15.5%
62,0630.0%0.00%0.0%
Q2 2014$951,000
+24.3%
62,0630.0%0.00%
+100.0%
Q1 2014$765,000
+6.4%
62,063
+0.2%
0.00%0.0%
Q4 2013$719,0000.0%61,924
+2.0%
0.00%0.0%
Q3 2013$719,000
+19.8%
60,684
+0.6%
0.00%0.0%
Q2 2013$600,00060,3500.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders